Retour
Fourchette du Jour
23,79 €
25,05 €
Fourchette 52 Semaines
9,98 €
29,65 €
Volume
1 212 913
Moyenne 50J / 200J
21,55 €
/
17,77 €
Clôture Précédente
24,51 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -8,1 | 0,2 |
| P/B | 10,7 | 3,0 |
| ROE % | -97,9 | 3,6 |
| Net Margin % | -20,2 | 3,8 |
| Rev Growth 5Y % | 9,6 | 9,9 |
| D/E | 2,9 | 0,2 |
Objectif de Cours des Analystes
Hold
30,50 €
+25.7%
Low: 21,00 €
High: 56,00 €
BPA Prévisionnel
-0,76 €
CA Est.
1,08B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
1,76 €
1,70 € – 1,84 €
|
1,64B | 3 |
| FY2029 |
1,29 €
1,25 € – 1,35 €
|
1,53B | 3 |
| FY2028 |
0,63 €
0,39 € – 1,27 €
|
1,36B | 9 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-19 | -0,09 € | -0,01 € | +89,3% |
| 2025-11-06 | -0,31 € | -0,31 € | 0,0% |
| 2025-08-06 | -0,40 € | -0,48 € | -20,0% |
| 2025-04-30 | -0,60 € | -0,67 € | -11,7% |
| 2025-02-26 | -0,25 € | -0,44 € | -76,0% |
| 2024-11-06 | -0,43 € | -0,36 € | +16,3% |
| 2024-08-01 | -0,54 € | -0,47 € | +13,0% |
| 2024-05-02 | -0,80 € | -0,63 € | +21,3% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Revenue grew 9,62% annually over 5 years — modest growth
Debt/Equity of 2,86 — high leverage
Negative free cash flow of -29,67M
Capital efficient — spends only 1,97% of revenue on capex
Croissance
Revenue Growth (5Y)
9,62%
Revenue (1Y)7,93%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-97,88%
ROIC-9,77%
Net Margin-20,17%
Op. Margin-7,70%
Sécurité
Debt / Equity
2,86
Current Ratio2,55
Interest Coverage-9,88
Valorisation
P/E Ratio
-8,10
Forward P/EN/A
P/B Ratio10,68
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 7,93% | Revenue Growth (3Y) | 16,50% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 9,62% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,01B | Net Income (TTM) | -204,71M |
| ROE | -97,88% | ROA | -23,23% |
| Gross Margin | 52,31% | Operating Margin | -7,70% |
| Net Margin | -20,17% | Free Cash Flow (TTM) | -29,67M |
| ROIC | -9,77% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 2,86 | Current Ratio | 2,55 |
| Interest Coverage | -9,88 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -8,10 | Forward P/E | N/A |
| P/B Ratio | 10,68 | P/S Ratio | 1,63 |
| PEG Ratio | -0,07 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 1,53 | Fwd Earnings Yield | N/A |
| FCF Yield | -1,79% | ||
| Market Cap | 1,66B | Enterprise Value | 2,01B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,01B | 940,20M | 747,72M | 801,22M | 702,80M |
| Net Income | -204,71M | -96,03M | -222,61M | -94,59M | 15,57M |
| EPS (Diluted) | -3,04 | -1,47 | -3,43 | -1,47 | 0,24 |
| Gross Profit | 530,85M | 489,57M | 367,69M | 412,99M | 376,22M |
| Operating Income | -78,12M | -99,13M | -233,23M | -92,85M | 22,65M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 881,11M | 967,66M | 952,66M | 1,05B | 905,14M |
| Total Liabilities | 725,94M | 704,56M | 639,03M | 612,84M | 472,03M |
| Shareholders' Equity | 155,17M | 263,10M | 313,63M | 439,95M | 433,11M |
| Total Debt | 444,48M | 473,57M | 415,67M | 419,88M | 314,67M |
| Cash & Equivalents | 90,63M | 69,23M | 58,87M | 172,52M | 71,18M |
| Current Assets | 618,14M | 724,49M | 747,99M | 849,98M | 811,52M |
| Current Liabilities | 242,72M | 247,05M | 195,26M | 165,29M | 131,86M |